Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program

被引:61
|
作者
Albores-Saavedra, Jorge [1 ]
Batich, Kristen [2 ]
Hossain, Sarah [3 ]
Henson, Donald E. [2 ]
Schwartz, Arnold M. [4 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico
[2] George Washington Univ, Inst Canc, Off Canc Prevent & Control, Washington, DC USA
[3] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Epidemiol & Biostat, Washington, DC USA
[4] George Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA
关键词
Carcinoid; Small-cell carcinoma; Neuroendocrine carcinoma; Gallbladder; Extrahepatic bile duct; PANCREATIC-POLYPEPTIDE; FOLLOW-UP; COMPLICATION;
D O I
10.1016/j.anndiagpath.2009.08.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Primary neuroendocrine tumors of the gallbladder (GB) and extrahepatic biliary ducts (EHBDs) include carcinoid tumors and small-cell carcinomas (SCCs). They are uncommon, and therefore, little is known about their demographics and clinical course. From National Cancer Institute's Surveillance, Epidemiology, and End Results program (1973-2005), we analyzed the demographics and 10-year relative survival rates of carcinoids and SCCs of the GB and EHBD according to histologic type and stage. There were 119 cases of carcinoid tumors and 54 cases of SCCs in the GB. There were 31 carcinoid tumors and 17 SCCs in the EHBD. The female/male ratios of carcinoids in the GB and EHBD were 2.4 and 1.6, respectively. The ratios for SCC in the GB and EHBD were 2.2 and 1.1, respectively. For the GB, the mean age of diagnosis for carcinoids was 64.5, and for SCC, it was 67.5. For the EHBD, the mean age was 58.2 for carcinoids and 68.4 for SCC. The 10-year survival rates were 36% for carcinoid tumors of the GB and 80% for carcinoid tumors of the EHBD. For SCC, the 10-year survival was 0% in the GB and EHBD. Carcinoid tumors and SCC of the extrahepatic biliary tree are uncommon neoplasms that differ in their demographics and biologic behavior, supporting the distinction of these 2 histopathologic types. Therefore, these tumors should be separately classified and not included in the single generic group of neuroendocrine carcinoma. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:378 / 383
页数:6
相关论文
共 48 条
  • [31] A prognostic nomogram based on lymph node ratio for postoperative vulvar squamous cell carcinoma from the Surveillance, Epidemiology, and End Results database: a retrospective cohort study
    Lei, Lei
    Tan, Liao
    Zhao, Xingping
    Zeng, Fei
    Xu, Dabao
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [32] Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database
    Jiajun Zhang
    Jin Zhang
    BMC Pulmonary Medicine, 23
  • [33] Atypical teratoid rhabdoid tumors: a population-based clinical outcomes study involving 174 patients from the Surveillance, Epidemiology, and End Results database (1973-2010)
    Lau, Christine S. M.
    Mahendraraj, Krishnaraj
    Chamberlain, Ronald S.
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 301 - 309
  • [34] Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database
    Zhang, Jiajun
    Zhang, Jin
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [35] Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program population-based study
    Bhattacharjee, Atanu
    Bhattacharyya, Tapesh
    Thomas, Abin
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2018, 6 (02): : 88 - 93
  • [36] Time trends in the use of surgery for stage I non-small cell lung cancer (NSCLC) and the impact on population survival: Analysis from the Surveillance, Epidemiology, and End Results (SEER) Program.
    Tran, Krystel
    Benjamin, John
    Woodford, Katrina
    Nardone, Louise
    Martin, Catherine
    Senthi, Sashendra
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Comparative analysis of characteristics, survival trends, and associated malignancies of B-cell and T-cell prolymphocytic leukemia: A surveillance, epidemiology, and end results (SEER) based study1998 to 2016.
    Attia, Doaa
    Attia, Sara Aly
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Oncological outcomes from surgical vs. non-surgical treatments for advanced hypopharyngeal squamous cell carcinoma: a surveillance, epidemiology, and end results-based study
    Fan, Yue
    Li, Shuguang
    Xia, Xin
    Yu, Shuting
    Zhu, Xiaoli
    Zhu, Yingying
    Diao, Wenwen
    Chen, Xingming
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (12): : 2379 - 2387
  • [39] Oncological outcomes from surgical vs. non-surgical treatments for advanced hypopharyngeal squamous cell carcinoma: a surveillance, epidemiology, and end results-based study
    Yue Fan
    Shuguang Li
    Xin Xia
    Shuting Yu
    Xiaoli Zhu
    Yingying Zhu
    Wenwen Diao
    Xingming Chen
    Clinical and Translational Oncology, 2022, 24 : 2379 - 2387
  • [40] Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST)
    Goldwasser, Deborah L.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (06) : 1280 - 1292